Mayer Schreiber
CEO @ Discovery Park
Sandwich, United Kingdom
Mayer Schreiber is a pre-seed investor at Discovery Park in Sandwich focused on Life Science and Biotechnology. ceo
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Mayer Schreiber invests in
Stages Mayer Schreiber invests in
Countries Mayer Schreiber invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 3 (75%)
- Biotechnology 3 (75%)
- Health Care 2 (50%)
- Biopharma 1 (25%)
- Pharmaceutical 1 (25%)
Stage
- Pre-Seed 3 (75%)
- Seed 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BugBiome
|
BugBiome is a biotech start-up offers a revolutionary solution to the age-old problem of mosquito bites. | $391.4K / Pre-Seed / Feb 12, 2024 | |
Ignota Labs
|
Ignota Labs recognizes that safety errors during the drug discovery process can result in expensive setbacks and delays in bringing life-changing medications to market. Ignota Labs world leading AI methods, which include deep learning and machine learning approaches, are intended to examine complicated molecular data and provide accurate toxicitypredictions. | Pre-Seed / Oct 11, 2022 | |
BoobyBiome
|
BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk. | $1.7M / Pre-Seed / Sep 08, 2022 | |
|
BoobyBiome
|
BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk. | $1.7M / Seed / Mar 29, 2022 |
Co-Investors
About Discovery Park
Discovery Park collaborates with life science companies to bring innovation to healthcare industry.
Discovery Park Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mayer Schreiber
CEO
|
|||
Rob Mingay
Senior Vice President NTE or Discovery Park and Senior Consultant Bluestone Government Relations
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mayer Schreiber invest in?
Mayer Schreiber invests primarily in Life Science, Biotechnology and Health Care startups, most often at Pre-Seed and Seed stage. Most of the 4 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mayer Schreiber?
Public channels for Mayer Schreiber include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Mayer Schreiber last invest?
The most recent investment recorded for Mayer Schreiber closed in Feb 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
